WO2006063963A1 - Methode pour accroitre la biomasse des vegetaux dans des conditions de stress - Google Patents
Methode pour accroitre la biomasse des vegetaux dans des conditions de stress Download PDFInfo
- Publication number
- WO2006063963A1 WO2006063963A1 PCT/EP2005/056629 EP2005056629W WO2006063963A1 WO 2006063963 A1 WO2006063963 A1 WO 2006063963A1 EP 2005056629 W EP2005056629 W EP 2005056629W WO 2006063963 A1 WO2006063963 A1 WO 2006063963A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wee1
- gene
- stress
- plants
- dna
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 239000002028 Biomass Substances 0.000 title description 2
- 101000621390 Homo sapiens Wee1-like protein kinase Proteins 0.000 claims abstract description 107
- 102100023037 Wee1-like protein kinase Human genes 0.000 claims abstract description 106
- 230000000694 effects Effects 0.000 claims abstract description 35
- 230000035882 stress Effects 0.000 claims abstract description 35
- 230000003828 downregulation Effects 0.000 claims abstract description 13
- 230000008641 drought stress Effects 0.000 claims abstract description 6
- 230000001105 regulatory effect Effects 0.000 claims description 13
- 230000036579 abiotic stress Effects 0.000 claims description 6
- 101150040313 Wee1 gene Proteins 0.000 abstract description 26
- 231100001160 nonlethal Toxicity 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 57
- 210000004027 cell Anatomy 0.000 description 37
- 108090000623 proteins and genes Proteins 0.000 description 30
- 230000014509 gene expression Effects 0.000 description 28
- 102000053187 Glucuronidase Human genes 0.000 description 25
- 108010060309 Glucuronidase Proteins 0.000 description 25
- 241000219194 Arabidopsis Species 0.000 description 22
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 19
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 16
- 230000004913 activation Effects 0.000 description 16
- 230000012010 growth Effects 0.000 description 15
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 14
- NOFOAYPPHIUXJR-APNQCZIXSA-N aphidicolin Chemical compound C1[C@@]23[C@@]4(C)CC[C@@H](O)[C@@](C)(CO)[C@@H]4CC[C@H]3C[C@H]1[C@](CO)(O)CC2 NOFOAYPPHIUXJR-APNQCZIXSA-N 0.000 description 14
- SEKZNWAQALMJNH-YZUCACDQSA-N aphidicolin Natural products C[C@]1(CO)CC[C@]23C[C@H]1C[C@@H]2CC[C@H]4[C@](C)(CO)[C@H](O)CC[C@]34C SEKZNWAQALMJNH-YZUCACDQSA-N 0.000 description 14
- 230000022131 cell cycle Effects 0.000 description 14
- 229960001330 hydroxycarbamide Drugs 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 230000006698 induction Effects 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 102000016736 Cyclin Human genes 0.000 description 12
- 238000010186 staining Methods 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 102000000872 ATM Human genes 0.000 description 11
- 101000785063 Homo sapiens Serine-protein kinase ATM Proteins 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 230000026731 phosphorylation Effects 0.000 description 11
- 238000006366 phosphorylation reaction Methods 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- 230000012753 DNA replication checkpoint Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 108050006400 Cyclin Proteins 0.000 description 9
- 101710158103 Cyclin-dependent kinase A-1 Proteins 0.000 description 9
- 231100000277 DNA damage Toxicity 0.000 description 9
- 108010084455 Zeocin Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- 108091007914 CDKs Proteins 0.000 description 8
- 230000005778 DNA damage Effects 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 230000006798 recombination Effects 0.000 description 8
- 238000005215 recombination Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 230000004543 DNA replication Effects 0.000 description 7
- 108091000080 Phosphotransferase Proteins 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 230000011278 mitosis Effects 0.000 description 7
- 102000020233 phosphotransferase Human genes 0.000 description 7
- 230000002786 root growth Effects 0.000 description 7
- 101001113440 Homo sapiens Poly [ADP-ribose] polymerase 2 Proteins 0.000 description 6
- 102000002490 Rad51 Recombinase Human genes 0.000 description 6
- 108010068097 Rad51 Recombinase Proteins 0.000 description 6
- 108700019146 Transgenes Proteins 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- QCUPYFTWJOZAOB-HWKANZROSA-N (e)-n-carbamoyl-2-ethylbut-2-enamide Chemical compound CC\C(=C/C)C(=O)NC(N)=O QCUPYFTWJOZAOB-HWKANZROSA-N 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 5
- 101710121785 Cyclin-dependent kinase B1-1 Proteins 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 101000797714 Oryza sativa subsp. japonica Cyclin-B1-3 Proteins 0.000 description 5
- 102100023652 Poly [ADP-ribose] polymerase 2 Human genes 0.000 description 5
- 239000005602 Propyzamide Substances 0.000 description 5
- 238000010240 RT-PCR analysis Methods 0.000 description 5
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 5
- PHNUZKMIPFFYSO-UHFFFAOYSA-N propyzamide Chemical compound C#CC(C)(C)NC(=O)C1=CC(Cl)=CC(Cl)=C1 PHNUZKMIPFFYSO-UHFFFAOYSA-N 0.000 description 5
- 230000028617 response to DNA damage stimulus Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 108010051219 Cre recombinase Proteins 0.000 description 4
- 230000010337 G2 phase Effects 0.000 description 4
- 101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 description 4
- 101000580039 Homo sapiens Ras-specific guanine nucleotide-releasing factor 1 Proteins 0.000 description 4
- 230000027311 M phase Effects 0.000 description 4
- 102100023330 M-phase inducer phosphatase 3 Human genes 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000006369 cell cycle progression Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000001744 histochemical effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 101150101778 mik1 gene Proteins 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 230000033616 DNA repair Effects 0.000 description 3
- 108700024394 Exon Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 102000001253 Protein Kinase Human genes 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000025084 cell cycle arrest Effects 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 231100000024 genotoxic Toxicity 0.000 description 3
- 230000001738 genotoxic effect Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000442 meristematic effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 230000008635 plant growth Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 108090000104 Actin-related protein 3 Proteins 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 101100210291 Arabidopsis thaliana WEE1 gene Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 230000012746 DNA damage checkpoint Effects 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000037060 G2 phase arrest Effects 0.000 description 2
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 2
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 2
- 230000018199 S phase Effects 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 2
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 description 2
- 108091006104 gene-regulatory proteins Proteins 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 239000011539 homogenization buffer Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000000113 radiomimetic effect Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 102200111112 rs397514590 Human genes 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 102000004899 14-3-3 Proteins Human genes 0.000 description 1
- 101710112812 14-3-3 protein Proteins 0.000 description 1
- XRKYMMUGXMWDAO-UHFFFAOYSA-N 2-(4-morpholinyl)-6-(1-thianthrenyl)-4-pyranone Chemical compound O1C(C=2C=3SC4=CC=CC=C4SC=3C=CC=2)=CC(=O)C=C1N1CCOCC1 XRKYMMUGXMWDAO-UHFFFAOYSA-N 0.000 description 1
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
- BUOYTFVLNZIELF-UHFFFAOYSA-N 2-phenyl-1h-indole-4,6-dicarboximidamide Chemical compound N1C2=CC(C(=N)N)=CC(C(N)=N)=C2C=C1C1=CC=CC=C1 BUOYTFVLNZIELF-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 108700018063 Arabidopsis AT4G02390 Proteins 0.000 description 1
- 108700004205 Arabidopsis HSP18.2 Proteins 0.000 description 1
- 101100112869 Arabidopsis thaliana CDKA-1 gene Proteins 0.000 description 1
- 101100300802 Arabidopsis thaliana RAD51 gene Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 239000012623 DNA damaging agent Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101710114154 Dual specificity phosphatase Cdc25 Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 230000037057 G1 phase arrest Effects 0.000 description 1
- 230000004707 G1/S transition Effects 0.000 description 1
- 230000037059 G2/M phase arrest Effects 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150003919 Parp2 gene Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
- 108010035235 Phleomycins Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108010064218 Poly (ADP-Ribose) Polymerase-1 Proteins 0.000 description 1
- 102100023712 Poly [ADP-ribose] polymerase 1 Human genes 0.000 description 1
- 108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 1
- 102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 1
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 101150063557 RAD51 gene Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- 101710150974 Regulator of chromosome condensation Proteins 0.000 description 1
- 102100039977 Regulator of chromosome condensation Human genes 0.000 description 1
- 108050006676 Retinoblastoma-related proteins Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
- 108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 101150078046 act2 gene Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 102000026825 cyclin binding proteins Human genes 0.000 description 1
- 108091008465 cyclin binding proteins Proteins 0.000 description 1
- 108010072268 cyclin-dependent kinase-activating kinase Proteins 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 230000012361 double-strand break repair Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 229940124642 endogenous agent Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229940093334 flomax Drugs 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000012869 germination medium Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000008600 mitotic progression Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008722 morphological abnormality Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 230000030147 nuclear export Effects 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000031264 response to gamma radiation Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- ZZIZZTHXZRDOFM-XFULWGLBSA-N tamsulosin hydrochloride Chemical compound [H+].[Cl-].CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-XFULWGLBSA-N 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
Definitions
- the present invention relates to the use of WEE1 to increase crop yield in stress conditions. More specifically, it relates to a downregulation of Wee 1 activity in conditions of non-lethal stress.
- a preferred embodiment is the use of a WEE1 knock out to increase seed weight, whereby the stress applied is drought stress.
- DNA damage by exogenous or endogenous agents is a constant treat to the integrity of the genome cells have developed a series of surveillance mechanisms that monitor the status and structure of the DNA during cell cycle progression.
- signal transduction cascades are activated, which halt cell cycle progression until completion of DNA repair.
- DNA damage is signaled by the ATM (ataxia telangiectasia mutated) and ATR (Rad3-related) phosphatidyl inositol 3-kinase-like protein kinases (Abraham, 2001; Bartek and Lucas, 2001; Kurz and Lees-Millar, 2004; Zhou and Elledge, 2000).
- ATM responds specifically to double stranded breaks, whereas ATR is primary activated by a block of the replication fork.
- ATM/ATR transduce the signal to CHK1/CHK2 kinases, which in turn modulate the activity of the effectors that directly participate in the G1/S transition, S-phase progression, or the G2/M transition (Chen and Sanchez, 2004; Sancar et al., 2004).
- Progression through the cell cycle is controlled by the ordered action of protein complexes that are at least composed of a catalytic subunit and a positive regulatory element, named Cyclin-Dependent Kinase (CDK) and cyclin, respectively.
- CDK Cyclin-Dependent Kinase
- the association of the CDK with its cyclin partner determines the activity of the complex, its stability, localization and substrate specificity (Murray et al., 2004; Pines and Rieder, 2001).
- the sequential activation of different cyclin/CDK complexes drives the cell cycle through the phosphorylation of many target substrates such as, nuclear envelop proteins, histons, cytoskeletal elements, components of the proteolysis machinery, and transcriptionally regulatory proteins such as the retinoblastoma- related protein.
- Cyclin/CDK activity is highly regulated on several levels. Control mechanisms include the regulated destruction of the cyclin subunit (Murray, 2004; Peters, 1998), the association of CDKs with regulatory proteins being different from cyclins (Lees, 1995), and the subcellular targeting of the cyclin/CDK complexes (Ohi and Gould, 1999).
- the most elaborated mechanism of regulation of CDK activation involves protein phosphorylation, that is largely responsible for explaining why the onset of mitosis occurs abruptly, whereas the accumulation of mitotic cyclins during S and G2 phase is a gradual process.
- CDK activity is positively regulated by the phosphorylation of a conserved threonine residue within the T-loop (Thr161 or equivalent residue) by the CDK activating kinases, and negatively through its phosphorylation of a single Tyrosine15 (in yeasts), or both Tyrosine15 and Threonine14 (in higher eukaryotes), by WEE1- family kinases (Berry and Gould, 1996). Phosphorylation of Tyr15 and Thr14 of the CDK subunit inhibits ATP fixation and blocks substrate binding.
- Prompt activation of cyclin/CDK activity at the G2/M boundary in yeast and mammals is achieved by a dual-specificity phosphatase CDC25, encoded by one gene in yeast, three isoforms in mammals.
- WEE1 preferentially phosphorylates the central cell cycle regulatory protein p34Cdc2. Therefore, WO0037645 suggested that down-regulation of WEE1, especially maize WEE1 , could be used to increase crop yield
- WEE1 takes part in the mechanism that ensures the onset of mitosis is coupled to the completion of DNA repair in cells that have suffered DNA damage, resulting in a slower growth and a decreased crop yield when the WEE1 gene is down-regulated under normal (stressed) field conditions.
- WEE1 gene is stress induced, down-regulation of WEE1 would not affect crop yield at all under hypothetical stress free conditions.
- down-regulation of the WEE1 gene has no negative effect under conditions of non-lethal stress. Down-regulation of WEE1 under conditions of sublethal stress could avoid an early stop of the cell cycle, and may therefore result in an increased crop yield under those conditions.
- a first aspect of the invention is the use of the WEE1 gene and/ or protein to increase crop yield in plants under conditions of sublethal stress.
- the Wee1 protein is a protein with the sequence set forth in genbank accession number Gl:22761819 , or with a sequence that is at least 70% identical to said sequence, preferentially 80% identical, even more preferentially 90% identical, and whereby said protein functions as a protein kinase.
- the Wee1 gene is a nucleic acid sequence encoding a WEE1 protein as described above. Gene as used herein refers to a polymeric form of nucleotides of any length, either ribonucleotides or deoxyribonucleotides. This term refers only to the primary structure of the molecule.
- the term includes double- and single- stranded DNA and RNA. It also includes known types of modifications, for example methylation, "caps" substitution of one or more of the naturally occurring nucleotides with an analogue. It includes, but is not limited to, the coding sequence, and may include non-translated intron sequences. However, as used here, the promoter sequence is not included; this sequence will be referred as "endogenous promoter" when it indicates the promoter naturally occurring upstream of the gene.
- Sublethal stress are those growth conditions in which a weel knock out is not negatively affected in growth, when compared to the WEE1 parental strain. Stress may be sublethal either because the level of stress is low as such and not affecting the plant growth, or it may be sublethal because it is local and only affecting some non-vital plant parts; And example of the latter non-lethal stress is the drought stress during seed ripening, which only affects the seeds, but not the total plant.
- said use of WEE1 is a down-regulation.
- said sublethal stress is abiotic stress.
- said abiotic stress is drought stress.
- a preferred embodiment of the invention is the use of WEE1 , according to the invention to increase see yield, preferably by a down-regulation of WEE1 during the phase of drought stress during seed ripening.
- Another aspect of the invention is a method to increase crop yield in plants comprising the down-regulation of WEE1 in function of the stress applied.
- said stress applied is abiotic stress.
- WEE1 stops the cell cycle at a stress level that as such is not harmful for the plant, resulting in a loss of crop yield. Delaying the WEE1 response to higher stress levels will result in a later block of the cell cycle and an increase of crop yield.
- the down-regulation of WEE1 should be carried out as an inverse function of the stress applied, being maximal under stress-free conditions, and being switched off under high stress conditions.
- This can be realized by operably linking the gene encoding WEE1 to a promoter that is down regulated in stress conditions. Operably linking refers to a juxtaposition wherein the components so described are in a relationship permitting them to function in their intended manner.
- a promoter sequence "operably linked" to a coding sequence is ligated in such a way that expression of the coding sequence is achieved under conditions compatible with the promoter sequence.
- Suitable stress down regulated promoters are known to the person skilled in the art and include, but are not limited too the promoters of the stress repressed genes genbank accession number AT1G74670, AT2G40610, AT1G69530 and AT5G51720. Delaying the WEE1 response can also be realized at protein level, eg by the production of an antibody that neutralizes the WEE1 kinase activity.
- the gene, encoding said antibody is operably linked to a promoter, preferably a weak, constitutive promoter, the WEE1 kinase activity will be neutralized, unless the production of WEE1 protein is high enough to overcome the inactivation by the antibody.
- FIG. 1 CDK phosphorylation in response to checkpoint activation.
- Arabidopsis cell cultures were treated with 10 ⁇ l/ml aphidicolin (A) or with 3 ⁇ M propyzamide (P) and mock-treated in controls (C).
- CDKs were purified using p10 CKS1At -Sepharose matrix, resolved by SDS-PAGE and immunoblotted using indicated antisera.
- FIG. 2 Transcriptional response of the WEE1 gene after activation of the DNA replication checkpoint.
- a and B Transcript levels of WEE1 and CDKA;1 in Arabidopsis cells treated with 40 rtiM hydroxyurea (A) or 10 ⁇ l/ml aphidicoline (B). Samples were harvested at the indicated time- points after adding the drugs. Gene expression was analysed by semi quantitative RT-PCR. The actine ACT2 gene was used as loading control.
- C and D Transgenic Arabidopsis roots harboring the WEE1 promoter fused to the GUS gene are growth in the absence (C) or presence (D) of hydroxyurea. Plants were stained for GUS activity 24 hrs after applying the drug.
- FIG. 3 Spatial expression pattern of WEE1. Promoter activity was visualized through histochemical GUS staining.
- A Young seedling showing strong GUS staining in the SAM
- B Root tissue showing GUS staining of vascular cells.
- C Young developing flower bud.
- D Mature flowers.
- Figure 4 Transcriptional activation of WEE1 in response to DNA damage checkpoint. Seedling harboring the WEE1 or PARP-2 promoter fused to the GUS reporter gene (WEE1:GUS and PARP-2:GUS) were treated with increasing concentrations of zeocin for 24 hrs. Activation of promoter activity was visualized through histochemical GUS staining.
- Figure 5 ATM-dependent induction of WEE1 in response to ⁇ -radiation.
- Figure 6 Molecular and phenotypic analysis of wee1-1 Arabidopsis plants.
- A Intron-exon organization of the WEE1 gene. Black and grey boxes represent exons, and lines indicate introns. Exons are numbered. The coding regions corresponding with the kinase domain are indicated in grey. The triangle corresponds to the T-DNA insertion in the GABI-Kat 270E05 line (wee1-1 mutant allele).
- B Two-step RT-PCR analysis performed with equal amounts of total RNA prepared from 8-day-old wild-type (CoI-O) and wee1-1 seedlings with primers that specifically amplify the WEE1 -coding sequence flanking the T-DNA insertion site.
- the actine 2 (ACT2) gene was used as loading control.
- C-H Wild type (C, E and G) and wee1-1 (D, F, and H) seeds germinated on MS plates, grown for 5 days and then transferred to control medium (C and D) or plates containing 1 rtiM HU (E and F) or 12 ⁇ g/ml of aphidicoline (G and H) for 5 days.
- J and K Wild type (J) and wee1-1 (K) seeds germinated on 12 ⁇ g/ml of aphidicoline.
- FIG. 7 Schematic diagram depicting the CRE-inducible transcriptional activation of the WEE1 transgene.
- A Under non-inducing conditions, the CRE recombinase, cloned under the control of the heat-shock inducible PHSP18.2 promoter, is not expressed and the Arath;CDK/l;7 promoter (PCDKA) drives the expression of the EGFP gene.
- the EGFP gene is followed by a stopcodon and polyadenylation signal, preventing the synthesis of WEE1.
- Figure 8 Molecular and phenotypic analysis of Arabidopsis plants after induction of WEE1 expression.
- A WEE1 expression levels as determined by semiquantitative RT-PCR analysis in two independent transgenic lines harboring the inducible WEE1 gene expression cassette. RNA was isolated from non-induced (-) and induced (+) plants. CDKA;1 and ACT2 expression levels were measured as control.
- B Phenotype (i, iii) and EGFP fluorescence (ii, iv) of transgenic roottips before (i, ii) and 3 days after (iii, iv) induction of WEE1 expression.
- Arabidopsis thaliana plants were grown under long-day conditions (16 h of light, 8 h of darkness) at 22°C on germination medium (Valvekens et al., 1988).
- the wee1-1 allele was obtained from the GABI-Kat T-DNA mutant collection (http://www.mpiz-koeln.mpq.de/GABI-
- Fragments corresponding to the promoter of the Arabidopsis HSP18.2 gene, the CRE recombinase-coding sequence, and the octopine synthase terminator (OCS3 1 ) sequence were assembled into the pZErOTM-2 vector and subsequently inserted into the pCAMBIA2200 vector, resulting into the pJCRE vector.
- the T-DNA region of the pJCRE vector contains the kanamycin resistance element which consists of the coding sequence of the neomycin phosphotransferase Il gene (nptll), flanked by the CaMV 35S promoter (P35S) and terminator (35S3 1 ) sequences.
- the Arath;CDK/l;1 promoter, the enhanced GFP gene (£GFP)-coding sequence flanked at a 5' end by the proximal loxP site, the OCS3 1 sequences (flanked at a 3' end by a distal loxP site), and the GATEWAYTM recombination site were assembled into the pZErOTM-2 vector.
- the cassette containing all the elements was subsequently cloned into the pCAMBIA1200 vector, resulting into the pJLOX vector.
- the T-DNA region of the pJLOX vector contains the hygromycine resistance element, which consists in the coding sequence of the hygromycin phosphotransferase Il gene (hptll), flanked by the CaMV 35S promoter (P35S) and terminator (35S3 1 ) sequences. Cloning details are available upon request.
- the WEE1 cDNA was introduced into the pJLOX vector by the GATEWAYTM recombinational cloning technology.
- the obtained Agrobacterium strains were used to generate stably transformed Arabidopsis using the floral dip transformation method (Clough and Bent, 1998). Transgenic plants were selected on kanamycine- and/or hygromycine-containing media and later transferred to soil for seed stock amplification.
- Genomic DNA was extracted from Arabidopsis leaves using the DNeasy Plant kit (Qiagen).
- RNA was extracted from Arabidopsis tissues and cultured cells using the Trizol reagent (Invitrogen).
- First-strand cDNA was prepared from 500 ng of total RNA with the Superscript RT Il kit (Invitrogen) and oligo(dT) 18 according to the manufacturer's instructions.
- a 0.2 ⁇ L aliquot of the total RT reaction volume (20 ⁇ L) was used as a template in a semi-quantitative RT-mediated PCR amplification ensuring that the amount of amplified product remained in linear proportion to the initial template present in the reaction.
- Protein extracts were prepared by grinding material in homogenization buffer (HB) (De Veylder et al., 1997). Protein concentrations were determined with the Protein Assay kit (Bio-Rad, Hercules, CA). CDKs were purified by p10 CKS1At -affinity chromatography using p10 CKS1At - Sepharose beads as described (Hemerly et al., 1995).
- SDS-PAGE and protein gel blots were performed according to standard procedures with primary anti-CDKA;1 and anti-CDKB1;1 (Porceddu et al., 2001) antibodies diluted 1/5000 and 1/2500, respectively, and a secondary horseradish peroxidase (HRP)-conjugated sheep anti-rabbit antibody (Amersham Pharmacia Biotech) diluted 1/5000, or with the mouse monoclonal HRP-conjugated anti-phosphotyrosine p- Tyr (PY99; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody diluted 1/50000. Protein detection was done by chemiluminescent procedure (NEN Life Science Products Inc., Boston, MA, USA).
- Leaves were harvested 21 days after sowing, cleared overnight in ethanol, stored in lactic acid for microscopy, and observed under a microscope fitted with differential interference contrast optics (Leica, Wetzlar, Germany).
- the total (blade) area was determined from pictures digitized directly with a digital camera (Axiocam; Zeiss, Jena, Germany) mounted on a binocular (Stemi SV11 ; Zeiss).
- DAPI 4,6-diamidino-2-phenylindole
- Example 1 Arabidopsis CDKA; 1 is tyrosine phosphorylated upon activation of the DNA replication checkpoint.
- CDK Tyr phosphorylation has been shown to occur upon G2/M arrest after cytokinin deprivation in tobacco and DNA replication checkpoint in Fucus zygotes (Zhang et al., 1996; Corellou et al., 2000).
- the replication inhibitor aphidicolin being an inhibitor of DNA polymerases ⁇ and ⁇ .
- Propyzamide was used to block cell cycle progression in mitosis by depolymerising the mitotic spindle (Planchais et al., 2000).
- CDKA;1 belongs to the archetype group of CDKs, characterized by the presence of a PSTAIRE amino-acid sequence motif in the cyclin binding protein domain.
- CDKB1;1 belongs to the group of plant-specific CDKs (Boudolf et al., 2004). As compared to control cells, neither drug treatment had effect on the abundance of CDKA;1 protein ( Figure 1).
- CDKB1;1 levels were slightly increased in the propyzamide-treated cells, which can be explained by the preferential expression of the CDKB1;1 gene during M phase (Porceddu et al., 2001; Boudolf et al., 2004).
- protein blots were probed with an anti-phosphotyrosine antibody. Whereas no antibody binding was detected in protein samples from control or propyzamide-treated cells ( Figure 1), a polypeptide band of the same electrophoretic mobility as CDKA; 1 was cross-reacting with the antibody in extracts prepared from the aphidicolin-treated cells. This analysis strongly indicates that CDKA; 1 is the target for Tyr phosphorylation upon activation of the DNA replication checkpoint.
- Example 2 The WEE1 gene is expressed in response to activation of the DNA replication checkpoint in cultured Arabidopsis cells and seedlings.
- transgenic Arabidopsis lines that contained as a transgene the 591-bp-long WEE1 promoter region fused to the ⁇ - glucuronidase (GUS) reporter gene.
- GUS ⁇ - glucuronidase
- Our data were also coherent with and the pattern of expression that can be deduced from a repository of 1434 publicly available microarray datasets using the GENEVESTIGATOR microarray analysis tool (Zimmermann et al., 2004).
- Example 3 ATM kinase is required for the activation of the WEE1 gene in response to DNA damage
- Figure 4 illustrates a typical reporter gene response in one-week-old seedlings treated with zeocin at concentration range from 1 ⁇ g/ml to 100 ⁇ g/ml.
- Zeocin induced a strong dose-dependent induction of GUS activity in PARP-2.GUS reporter lines, demonstrating the efficiency of zeocin as a genotoxic drug (Figure 4).
- WEE1 promoter activity was induced by the zeocin treatment; both in the root ( Figure 4) and the shoot tissues.
- Example 4 Plants with a loss-of-function mutation in WEE1 are hypersensitive to perturbations of DNA metabolism
- Seedlings of both genotypes had mature cotyledons and the first fully- expanded leaves of similar size and contained the same number of abaxial epidermal pavement cells (Table 1 ). Also root growth rates were similar for wild type and mutant plants ( Figure 6C, 6D and 6I). As it has been proposed that in maize the WEE1 gene can control the endocycle, the distribution profiles of ploidy levels in leaf cells of wild type and mutant plants were compared, but no differences were found (Table 2). These data illustrate that in Arabidopsis leaves and roots the WEE1 activity is not required for cell division or endoreduplication under normal growth conditions. Next, we characterized the growth of wee1-1 mutant plants in the presence of drugs that interfere with DNA replication.
- Wild type and wee1-1 plants were germinated and grown on control medium for 5 days, and then transferred on control medium, or medium supplemented with either HU or aphidicolin at concentrations that had mild but perceptible effects on growth of the wild type root (Culligan et al., 2004).
- the length of wild type roots was reduced by 32% and 72% respectively, as compared to non-treated plants (Fig 6C, 6E, 6G and 6I).
- wee1-1 root growth was reduced by more than 70% in the presence of HU (Fig 6F and 6I), and mutant root growth was totally arrested in the presence of aphidicolin (Fig 6H and 61).
- Example 5 Lack of WEE1 activity results in cell death in the presence of genotoxic stress
- wee1-1 mutant is hypersensitive to DNA replication stress.
- control and wee1- ⁇ plants were transferred 5 days after germination to control medium or medium containing aphidicolin.
- Four days after transfer root tips of these plants were harvested and a real time PCR was performed.
- WEE1 expression was three fold upregulated in control root tips under stress, no WEE1 expression was observed in the wee1-1 mutant.
- CYCB1;1 expression was found to be three fold upregulated in the control root tip, suggesting a G2 arrest (Culligan et al., 2004), but was 7.5 fold upregulated in the wee1-1 mutant.
- This accumulation of CYCB1;1 transcripts in stressed wee1-1 root tips could be due to an arrest of the cell cycle in the G2- or M-phase. It is expected that the wee1-1 cells, because of a lack of WEE1, cannot arrest their cell cycle to allow DNA repair on activation of the replication checkpoint and will enter the mitosis with incompletely replicated genomes. This supposedly results in an arrest of mitosis leading to meristematic failure and cell death. To analyze the amount of cells dying in the root tip, an Evans blue staining was performed. This cell-death staining showed more dying cells in the wee1-1 mutant than in control plants when growing under genotoxic conditions.
- ATM and ART operate as signal transducing kinases in regulatory cascades that elicit the DNA damage response, which include cell cycle arrest.
- Previous results showed that ATM-dependent activation of the WEE1 gene is a part of the DNA damage response in Arabidopsis.
- WEE1 kinase activity was a part of the DNA damage response in Arabidopsis.
- induced WEE1 transcript levels result in higher WEE1 protein production, which ultimately lead to the arrest of the plant cell cycle.
- Seeds of the WEE1 knock out were analysed on size and weight.
- the WEE1 knock out seeds are clearly bigger than the control seeds ( Figure 9).
- For analysing the weight a certain weight of seeds was taken from the seeds stock, and the number of seeds was counted. Average seed weight was calculated by dividing the total weight by the number of seeds counted. The results are summarized in Table 3.
- a S/M DNA replication checkpoint prevents nuclear and cytoplasmic events of cell division including centrosomal axis alignment and inhibits activation of cyclin-dependent kinase-like proteins in fucoid zygotes. Development 127, 1651-1660. Christensen, P.U., Bentley, N.J., Martinho, R.G., Nielsen, O., and Carr, A.M. (2000). Mik1 levels accumulate in S phase and may mediate an intrinsic link between S phase and mitosis.
- Arabidopsis CksiAt protein binds to the cyclin-dependent kinases Cdc2aAt and Cdc2bAt.
- Ionising radiation induces the expression of PARP-1 and PARP-2 genes in Arabidopsis.
- AtATM is essential for meiosis and the somatic response to DNA damage in plants. Plant
- SimpleSearch a flanking sequence tag (FST) database for the identification of T-DNA insertion mutants in Arabidopsis thaliana. Bioinformatics 19, 1441-1442.
- Chem. 276, 36354-36360 Rhind, N., and Russell, P. (2001). Roles of the mitotic inhibitors Wee1 and Mik1 in the G 2 DNA damage and replication checkpoints. MoI. Cell. Biol. 21 , 1499-1508. Sancar, A., Lindsey-Boltz, L.A., ⁇ nsal-Kagmaz, K., and Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73,
- a WEE1 homologue from Arabidopsis thaliana Planta 215, 518-522.
- Valvekens D., Van Montagu, M. and Van Lijsebettens, M. (1988) Agrobacterium tumefaciens- mediated transformation ofArabidopsis thaliana root explants by using kanamycin selection. Proc. Natl. Acad. Sci USA 85, 5536-5540. Vandepoele, K., Raes, J., De Veylder, L., Rouze, P., Rombauts, S., and Inze, D. (2002).
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106581 | 2004-12-14 | ||
EP04106581.4 | 2004-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006063963A1 true WO2006063963A1 (fr) | 2006-06-22 |
Family
ID=36102607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/056629 WO2006063963A1 (fr) | 2004-12-14 | 2005-12-09 | Methode pour accroitre la biomasse des vegetaux dans des conditions de stress |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006063963A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010033564A1 (fr) * | 2008-09-17 | 2010-03-25 | Ceres, Inc. | Plantes transgéniques présentant une biomasse augmentée |
EP2304036A4 (fr) * | 2008-06-13 | 2012-01-25 | Performance Plants Inc | Procédés et moyens d augmentation de l efficacité d utilisation d eau par des plantes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054489A1 (fr) * | 1998-04-21 | 1999-10-28 | Cropdesign N.V. | Vegetaux tolerants aux agressions |
WO2000037645A2 (fr) * | 1998-12-23 | 2000-06-29 | Pioneer Hi-Bred International, Inc. | Acides nucleiques intervenant dans le cycle cellulaire, polypeptides et leurs utilisations |
-
2005
- 2005-12-09 WO PCT/EP2005/056629 patent/WO2006063963A1/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999054489A1 (fr) * | 1998-04-21 | 1999-10-28 | Cropdesign N.V. | Vegetaux tolerants aux agressions |
WO2000037645A2 (fr) * | 1998-12-23 | 2000-06-29 | Pioneer Hi-Bred International, Inc. | Acides nucleiques intervenant dans le cycle cellulaire, polypeptides et leurs utilisations |
Non-Patent Citations (5)
Title |
---|
CHEN I-PENG ET AL: "The transcriptional response of Arabidopsis to genotoxic stress: A high-density colony array study (HDCA).", PLANT JOURNAL, vol. 35, no. 6, September 2003 (2003-09-01), pages 771 - 786, XP002377233, ISSN: 0960-7412 * |
SCHUPPLER ET AL: "Effect of water stress on cell division and cell-division-cycle 2-like cell-cycle kinase activity in wheat leaves", PLANT PHYSIOLOGY, AMERICAN SOCIETY OF PLANT PHYSIOLOGISTS, ROCKVILLE, MD, US, vol. 117, no. 2, June 1998 (1998-06-01), pages 667 - 678, XP002114001, ISSN: 0032-0889 * |
SORRELL DAVID A ET AL: "A WEE1 homologue from Arabidopsis thaliana", PLANTA (BERLIN), vol. 215, no. 3, July 2002 (2002-07-01), pages 518 - 522, XP002377234, ISSN: 0032-0935 * |
STALS H ET AL: "When plant cells decide to divide", TRENDS IN PLANT SCIENCE, ELSEVIER SCIENCE, OXFORD, GB, vol. 6, no. 8, August 2001 (2001-08-01), pages 359 - 364, XP002239159, ISSN: 1360-1385 * |
SUN YUEJIN ET AL: "Characterization of maize (Zea mays L.) Wee1 and its activity in developing endosperm", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 96, no. 7, 30 March 1999 (1999-03-30), pages 4180 - 4185, XP002140189, ISSN: 0027-8424 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2304036A4 (fr) * | 2008-06-13 | 2012-01-25 | Performance Plants Inc | Procédés et moyens d augmentation de l efficacité d utilisation d eau par des plantes |
AU2009259015B2 (en) * | 2008-06-13 | 2014-09-11 | Performance Plants Inc. | Methods and means of increasing the water use efficiency of plants |
US9453238B2 (en) | 2008-06-13 | 2016-09-27 | Performance Plants, Inc. | Methods and means of increasing the water use efficiency of plants |
CN107022567A (zh) * | 2008-06-13 | 2017-08-08 | 波夫曼斯种植公司 | 提高植物水分利用效率的方法和手段 |
US10036035B2 (en) | 2008-06-13 | 2018-07-31 | Performance Plants, Inc. | Methods and means of increasing the water use efficiency of plants |
US10508283B2 (en) | 2008-06-13 | 2019-12-17 | Performance Plants, Inc. | Methods and means of increasing the water use efficiency of plants |
US11220696B2 (en) | 2008-06-13 | 2022-01-11 | Performance Plants, Inc. | Methods and means of increasing the water use efficiency of plants |
US11453889B2 (en) | 2008-06-13 | 2022-09-27 | Performance Plants, Inc. | Vector comprising sorghum terminator and method of use |
US11827895B2 (en) | 2008-06-13 | 2023-11-28 | Performance Plants, Inc. | Vector comprising sorghum promotor and method of use |
US11913008B2 (en) | 2008-06-13 | 2024-02-27 | Performance Plants, Inc. | Vector comprising sorghum terminator and method of use |
US12123008B2 (en) | 2008-06-13 | 2024-10-22 | Performance Plants, Inc. | Methods and means of increasing the water use efficiency of plants |
WO2010033564A1 (fr) * | 2008-09-17 | 2010-03-25 | Ceres, Inc. | Plantes transgéniques présentant une biomasse augmentée |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Schutter et al. | Arabidopsis WEE1 kinase controls cell cycle arrest in response to activation of the DNA integrity checkpoint | |
Eloy et al. | The APC/C subunit 10 plays an essential role in cell proliferation during leaf development | |
Liu et al. | The ASK1 and ASK2 genes are essential for Arabidopsis early development | |
Wang et al. | HUA ENHANCER3 reveals a role for a cyclin-dependent protein kinase in the specification of floral organ identity in Arabidopsis | |
Huang et al. | The Arabidopsis SUMO E3 ligase AtMMS21, a homologue of NSE2/MMS21, regulates cell proliferation in the root | |
Garcia et al. | A small plant-specific protein family of ABI five binding proteins (AFPs) regulates stress response in germinating Arabidopsis seeds and seedlings | |
Shen et al. | Null mutation of AtCUL1 causes arrest in early embryogenesis in Arabidopsis | |
Stirnberg et al. | MAX2 participates in an SCF complex which acts locally at the node to suppress shoot branching | |
Haga et al. | R1R2R3-Myb proteins positively regulate cytokinesis through activation of KNOLLE transcription in Arabidopsis thaliana | |
Guo et al. | MID1 plays an important role in response to drought stress during reproductive development | |
Zhou et al. | Effects of co-expressing the plant CDK inhibitor ICK1 and D-type cyclin genes on plant growth, cell size and ploidy in Arabidopsis thaliana | |
Bellec et al. | Pasticcino2 is a protein tyrosine phosphatase‐like involved in cell proliferation and differentiation in Arabidopsis | |
Nakagawa et al. | Overexpression of a petunia zinc‐finger gene alters cytokinin metabolism and plant forms | |
Chen et al. | Os ORC 3 is required for lateral root development in rice | |
US20070136889A1 (en) | Method and means for modulating plant cell cycle proteins and their use in plant cell growth control | |
Grimault et al. | Zm ZHOUPI, an endosperm‐specific basic helix–loop–helix transcription factor involved in maize seed development | |
Rojas et al. | Overexpression of the Arabidopsis anaphase promoting complex subunit CDC27a increases growth rate and organ size | |
Fang et al. | Reduction of ATP ase activity in the rice kinesin protein Stemless Dwarf 1 inhibits cell division and organ development | |
Ashtiyani et al. | AtHaspin phosphorylates histone H3 at threonine 3 during mitosis and contributes to embryonic patterning in Arabidopsis | |
Kougioumoutzi et al. | SIMPLE LEAF 3 encodes a ribosome‐associated protein required for leaflet development in C ardamine hirsuta | |
Rigoulot et al. | Populus trichocarpa clade A PP2C protein phosphatases: their stress-induced expression patterns, interactions in core abscisic acid signaling, and potential for regulation of growth and development | |
Sozzani et al. | The E2FD/DEL2 factor is a component of a regulatory network controlling cell proliferation and development in Arabidopsis | |
Yoon et al. | CTP synthase is essential for early endosperm development by regulating nuclei spacing | |
Hashida et al. | Two ANGUSTIFOLIA genes regulate gametophore and sporophyte development in Physcomitrella patens | |
Li et al. | Arabidopsis F‐BOX STRESS INDUCED 4 is required to repress excessive divisions in stomatal development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05826364 Country of ref document: EP Kind code of ref document: A1 |